USANA Health Sciences

Quarterly Financials

Values in thousands 2024-12-31 2024-09-30 2024-06-30 2024-03-31
Revenue
$213,613
$200,221
$212,869
$227,800
Gross Profit
175,060
160,964
168,723
184,731
EBITDA
16,442
24,216
23,542
32,247
EBIT
10,558
18,657
17,840
27,163
Net Income
4,484
10,607
10,432
16,537
Net Change In Cash
213,613
200,221
212,869
227,800
Free Cash Flow
3,983
27,135
5,319
14,482
Cash
181,768
364,889
332,423
328,336
Basic Shares
19,104
19,083
19,159
19,302

Annual Financials

Values in thousands 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Revenue
$854,503
$921,010
$998,601
$1,186,464
Gross Profit
693,291
744,317
804,711
968,566
EBITDA
98,861
123,110
129,024
192,385
EBIT
76,632
102,715
107,614
170,192
Net Income
42,030
63,788
69,350
116,505
Net Change In Cash
854,503
921,010
998,601
1,186,464
Cost of Revenue
-74,372
Free Cash Flow
50,919
56,147
93,502
108,464
Cash
181,768
330,420
288,420
239,832
Basic Shares
19,162
19,345
19,310
20,343

Earnings Calls

Quarter EPS
2024-12-31
$0.64
2024-09-30
$0.56
2024-06-30
$0.54
2024-03-31
$0.86